Subscribe to our Newsletters !!

    Lung Cancer

    Novel medication could improve future and quality for patients with difficult to-treat malignant growths

    The Sheffield researchers founded the spin-out Modulus Oncology with a group of experienced biotech entrepreneurs to fast-track the drug into clinical testing over two decades. The researchers founded the spin-out firm Modulus Oncology, along with a team of seasoned biotech entrepreneurs, to fast-track the drug into clinical testing over two years. The Sheffield team made

    Microorganisms in the lungs could impact lung cancer progression and prognosis

    Bottom Line: Enrichment of the lungs with oral commensal microbes has been correlated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer. Journal in Which the research was Published: Cancer Discovery, a journal of the American Association for Cancer Research Author: Leopoldo Segal, MD, director of the Lung Microbiome Program,

    Digital chest drainage systems could help reduce COVID-19 spread, research show

    Pioneering research, which reveals digital chest drains generate and disperse less aerosol generated particles in comparison to traditional water seal systems, has been published in the Seminars in Thoracic and Cardiovascular Surgery journal. The research was led by a group of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust — home to one

    Scientists distinguish new compound that may forestall heart arrhythmia risk from basic drugs

    Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that causes regeneration, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs might have a more therapeutic benefit at higher doses,

    Clinithink and AstraZeneca Launch First of its Kind AI Project Aimed at Detecting Early-Stage Lung Cancer

    Clinithink, the company that has developed the world’s first Healthcare AI capable of truly understanding unstructured medical notes, has partnered with AstraZeneca Oncology UK in a new project that aims to find patients with lung cancer at an early stage where treatment can be more effective. The project announced today hopes to demonstrate potential savings